Skip to search formSkip to main contentSkip to account menu

Cerubidine

National Institutes of Health

Related topics

Related topics

3 relations
Daunoblastin

Broader (2)

DaunorubicinDaunorubicin Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Azacytidine plus Thalidomide in Myelodysplastic Syndromes and Acute Myelogenous Leukemia
The standard therapy for acute myelogenous leukemia (AML) continues to be based on cytarabine (ara-C, DepoCyt, Enzon), typically… 
Review
2000
Review
2000
Roles of Nuclear Factor-k B , p 53 , and p 21 / WAF 1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis 1
Daunomycin is a potent inducer of p53 and NF-kB transcription factors. It is also able to increase the amount of the p21 cyclin… 
1985
1985
Serum anti-platelet activity in acute leukemias (AL) and chronic thrombocytopenic purpura (ITP).
Serum anti-platelet activity in 44 patients with acute leukemia (AL), 19 patients with idiopathic thrombocytopenic purpura (ITP… 
1984
1984
Hyperpigmentation with daunorubicin therapy.
Pigmentary aberrations are known side effects of cancer chemotherapy. Doxorubicin hydrochloride (Adriamycin) is one of the… 
1984
1984
Introduction to Cerubidine® (daunorubicin) symposium
1981
1981
[Clinical usefulness of determination of the sensitivity of myeloblastic leukemia cells to antiproliferative drugs in cell culture in vivo].
In 15 patients with acute myeloblastic leukaemia and 4 with acute myelomonocytic leukaemia the sensitivity of blast cells was… 
1980
1980
Daunorubicin (Cerubidine).
1968
1968
[Cytologic modifications of acute myeloblastic leukemia and sympathicogonioma treated with Cerubidine].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)